Xue Mengjun
Managing Partner @ Pan-Lin Capital
Xue Mengjun is a Series A investor at Pan-Lin Capital focused on Biotechnology and Manufacturing. Graduated from Shanghai University of Finance, Mr. Xue Mengjun has a bachelor degree in economics and Chinese CPA qualification. Formerly he was Investment Director of Venture Capital Times, Deputy General Manager of Bridge Securities’ investment banking headquarters and Operations Director of Asia Business Consulting. He has over 15 years ofprofessional experience in investment banking and equity investment business areas.Mr. Xue Mengjun is versed of and has a deep understanding of the domestic capital market, and has an extensive network of resources, with senior business experience in investment banking. He understands and well knows operations of listed companies, especially in the field of Mergers and Acquisitions. He has a wealth of operational experience and combat capability. He served as a project leader and successfully completed more than a dozen of cases of mergers and acquisitions of listed companies, including Huchang Special Steel, Chengdu Hualian, Donkey-Hide Gelatin, Erie Shares, Jinfeng Investment, Gansu Changfeng, Shaanxi Changling projects and all these projects achieved the expected objectives. The project of Xi'an Hi-Tech backdoor Huchang Special Steel valued up to billions of RMB and has become a classic case in the domestic capital M & A markets.Mr. Xue Mengjun was engaged in the equity investments in environment, consumer, TMT field for many years, and successfully completed a number of projects. He has accumulated a wealth of practical experience in enterprise value judgment, due diligence, after investment management, project exit, follow-up financing, financial management and can help enhance the value of invested companies quickly. In Panlin Capital, Mr. Xue Mengjun was responsible for the Dream Game, Huaxia-phytorestore, Sheng Nuoji and other projects, and involved in Eastern Pioneer, Kangtai biological projects. Now he is a Director of Huaxia-Phytorestore.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Xue Mengjun invests in
Stages Xue Mengjun invests in
Countries Xue Mengjun invests in
Investment Focus
Industry
- Biotechnology 2 (67%)
- Manufacturing 2 (67%)
- Medical 1 (33%)
- Biopharma 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Dishi Medical
|
Dishi Medical is a company that manufactures Ophthalmic Medical Devices and other micro-assisted robots supported by biotechnology. | Series A / Jan 19, 2026 | |
|
Dishi Medical
|
Dishi Medical is a company that manufactures Ophthalmic Medical Devices and other micro-assisted robots supported by biotechnology. | $13.7M / Series A / Apr 27, 2025 | |
Tingke Biotechnology
|
Tingke Biotechnology develops microfluidic products for industry partners. They offer products that include vitro diagnostics, organ chips, nanomedicine, material synthesis, food safety, and environmental protection testing. | Series A / Mar 03, 2023 |
Co-Investors
Fortune Venture Capital
1 deal together
About Pan-Lin Capital
Panlin Capital, following the investment theme of ‘consumption upgrade driven by technology innovation’, targets the start-ups which are specialized in biotechnology and data intelligence sectors.As a venture capital corporation, Panlin Capital has became professional as well as influential in the biotechnology and data intelligence sectors.Identify the entrepreneurs among scientists.Enable the innovators among entrepreneurs。
Pan-Lin Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Li Yuhui
Founding Managing Partner, Executive Director
|
|||
Tan Huidong
Co-Founder, Partner & Supervisor
|
|||
|
Xue Mengjun
Managing Partner
|
|||
|
Yuheng Liu
Co-Founder & Partner
|
|||
Zhongbo Wang
Vice President and Chief Financial Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Xue Mengjun invest in?
Xue Mengjun invests primarily in Biotechnology, Manufacturing and Medical startups, most often at Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Xue Mengjun last invest?
The most recent investment recorded for Xue Mengjun closed in Jan 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
